| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |